A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects ...

REDMOND, WA, USA I October 14, 2024 I SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the U.S. Food and Drug ...

A groundbreaking study reveals the powerful antibacterial properties of thyme ('Thymus vulgaris'), suggesting its potential ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

A UB study has found that “forever chemicals” are more toxic when mixed together in the environment and in the human body.

The AnTenGager™ Platform is a proprietary “2+1” T cell engager (TCE) platform developed by Antengene. AnTenGager™ TCE simultaneously binds to disease-associated antigens (targets) and a unique ...

The good news: Most of the tested chemicals' individual cytotoxicity and neurotoxicity levels were relatively low. The bad news: the chemicals acted together to make the entire mixture toxic. "Though ...

The good news: Most of the tested chemicals' individual cytotoxicity and neurotoxicity levels were relatively low. The bad ...